Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Raw Materials (2023 - 2025)

Historic Raw Materials for Krystal Biotech (KRYS) over the last 3 years, with Q3 2025 value amounting to $14.6 million.

  • Krystal Biotech's Raw Materials rose 6209.78% to $14.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.6 million, marking a year-over-year increase of 6209.78%. This contributed to the annual value of $13.6 million for FY2024, which is 33243.5% up from last year.
  • Krystal Biotech's Raw Materials amounted to $14.6 million in Q3 2025, which was up 6209.78% from $14.1 million recorded in Q2 2025.
  • In the past 5 years, Krystal Biotech's Raw Materials registered a high of $15.1 million during Q1 2025, and its lowest value of $3.2 million during Q4 2023.
  • Moreover, its 3-year median value for Raw Materials was $11.3 million (2024), whereas its average is $9.9 million.
  • Per our database at Business Quant, Krystal Biotech's Raw Materials skyrocketed by 33243.5% in 2024 and then surged by 6209.78% in 2025.
  • Krystal Biotech's Raw Materials (Quarter) stood at $3.2 million in 2023, then skyrocketed by 332.44% to $13.6 million in 2024, then increased by 6.74% to $14.6 million in 2025.
  • Its Raw Materials stands at $14.6 million for Q3 2025, versus $14.1 million for Q2 2025 and $15.1 million for Q1 2025.